Institutional BioSafety Committee, Forms and Instructions
To ensure compliance with the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules, the HHRI has established an Institutional Biosafety Committee (IBC).
The purpose of this committee is to ensure that research at the HHRI is in compliance with NIH policies that provide for safe experimental conduct.
The goal of the IBC is to assist the Principle Investigator in determining safeguards that should be implemented to ensure that the research is conducted in full conformity with the provisions of the NIH Guidelines.
The IBC will be responsible for oversight of research activities involving infectious agents (bacteria, viruses, protozoans, fungi, etc.), recombinant DNA, and biological toxins (endotoxins, enterotoxins, venoms, etc.).
HHRI researchers using these potentially biohazardous reagents must register their work with the IBC by submitting a 1-page form for committee review and approval. Please submit all applications and questions to IBC@hhrinstitute.org. The IBC meets as needed to review submitted projects.